Healthcare Industry News: joint replacement
News Release - February 1, 2006
MAKO Surgical Corp. Secures Rights to Innovative Orthopaedic Implant MaterialHOLLYWOOD, Fla., Feb. 1 (HSMN NewsFeed) -- MAKO Surgical Corp., an emerging orthopaedic medical technology company, presenting at the 2006 Florida Venture Forum on February 1, in Ponte Vedra Beach, Florida, today announced a comprehensive sponsored research plan and licensing arrangement with the University of Florida (UF) whereby MAKO secured all rights in medical applications to a low friction, ultra low wear rate polymer, referred to by University scientists as "Material X." UF scientists believe that a component made from this PEEK/PTFE nano composite material could prove significantly more durable than other existing materials. While Material X has potential applicability in many areas of medicine, MAKO, which is targeting various stages of the $4 billion knee replacement surgery sector, anticipates employing the material in the development of its unique knee implant and bone resurfacing technologies for potentially dramatic results. A sponsored research program is already underway to ensure that Material X is biocompatible for humans and would provide the expected performance when used as a bearing material for an orthopaedic joint replacement.
"We are encouraged by the early results of our research with UF and excited about how this potentially game-changing material, when coupled with our proprietary technology, will enable surgeons to advance standard surgical approaches treating degenerative diseases of the knee," said MAKO's President and CEO, Dr. Maurice R. Ferre. "Ultimately, Material X may be the ideal complement to our Makoplasty(TM) therapy, whereby we will enable the delivery of a joint implant through a keyhole incision, but also ensure the implant itself will resist wear well beyond today's implant standards."
MAKO's proprietary solution, called Makoplasty(TM), targets degenerative diseases of the knee and goes beyond traditional minimally invasive procedures to enable rapid patient recovery and improved anatomical functionality. MAKO's proprietary technology, the Haptic Guidance System(TM), enables surgeons to digitally sculpt and preserve bone tissue through "keyhole" incisions in a highly accurate, reproducible, yet simple and easy to learn manner.
"The University of Florida is pleased to expand our already substantial research and commercial relationship with MAKO, a company recognized by the Florida Venture Forum for high-growth potential," said David Day, Director of the Office of Technology Licensing and Sid Martin Biotechnology Development Incubator for the University. "Like MAKO, the University of Florida is driven to develop unique solutions for the knee replacement market. Material X should nicely complement MAKO's existing technologies in orthopaedic implant design and surgical robotics, towards the ultimate goals of improved patient outcome and enhanced quality of life."
About MAKO Surgical Corporation
MAKO Surgical Corp., located in Hollywood, Florida, is a privately-held emerging orthopaedic medical device company developing advanced technologies and solutions for the rapidly growing minimally invasive joint market. MAKO is targeting the $4 billion worldwide knee surgery market. MAKO's proprietary solution, called Makoplasty(TM), provides novel therapies for degenerative diseases of the knee and goes beyond traditional minimally invasive procedures to enable rapid patient recovery and improved anatomical functionality. MAKO is committed to reducing pain, improving surgical approach and outcomes, and restoring function and quality of life for millions of people worldwide. For more information, please contact the company at firstname.lastname@example.org .
About University of Florida Office of Technology Licensing
The University of Florida's Office of Technology Licensing (OTL) is the University's commercialization center. It receives almost 300 disclosures per year generated from the cutting-edge research that takes place from all around the campus. OTL has partnered with companies throughout Florida, the Southeast and nationally to assist in the movement of technologies to the marketplace and welcomes the opportunity to work with companies interested in such a partnership. For more information, visit the website at http://www.otl.uf.edu or email email@example.com.
Source: MAKO Surgical
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.